Literature DB >> 10903750

The complexity of protective immunity against liver-stage malaria.

D L Doolan1, S L Hoffman.   

Abstract

Sterile protective immunity against challenge with Plasmodium spp. sporozoites can be induced in multiple model systems and humans by immunization with radiation-attenuated Plasmodium spp. sporozoites. The infected hepatocyte has been established as the primary target of this protection, but the underlying mechanisms have not been completely defined. Abs, CD8+ T cells, CD4+ T cells, cytokines (including IFN-gamma and IL-12), and NO have all been implicated as critical effectors. Here, we have investigated the mechanisms of protective immunity induced by immunization with different vaccine delivery systems (irradiated sporozoites, plasmid DNA, synthetic peptide/adjuvant, and multiple Ag peptide) in genetically distinct inbred strains, genetically modified mice, and outbred mice. We establish that there is a marked diversity of T cell-dependent immune responses that mediate sterile protective immunity against liver-stage malaria. Furthermore, we demonstrate that distinct mechanisms of protection are induced in different strains of inbred mice by a single method of immunization, and in the same strain by different methods of immunization. These data underscore the complexity of the murine host response to a parasitic infection and suggest that an outbred human population may behave similarly. Data nevertheless suggest that a pre-erythrocytic-stage vaccine should be designed to induce CD8+ T cell- and IFN-gamma-mediated immune responses and that IFN-gamma responses may represent an in vitro correlate of pre-erythrocytic-stage protective immunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903750     DOI: 10.4049/jimmunol.165.3.1453

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  141 in total

1.  Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.

Authors:  R Wang; J Epstein; F M Baraceros; E J Gorak; Y Charoenvit; D J Carucci; R C Hedstrom; N Rahardjo; T Gay; P Hobart; R Stout; T R Jones; T L Richie; S E Parker; D L Doolan; J Norman; S L Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

2.  Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.

Authors:  M B Joshi; A A Gam; R A Boykins; S Kumar; J Sacci; S L Hoffman; H L Nakhasi; R T Kenney
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 3.  Large screen approaches to identify novel malaria vaccine candidates.

Authors:  D Huw Davies; Patrick Duffy; Jean-Luc Bodmer; Philip L Felgner; Denise L Doolan
Journal:  Vaccine       Date:  2015-10-01       Impact factor: 3.641

4.  HLA-A2 supertype-restricted cell-mediated immunity by peripheral blood mononuclear cells derived from Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls.

Authors:  Kirsten E Lyke; Robin B Burges; Yacouba Cissoko; Lansana Sangare; Abdoulaye Kone; Modibo Dao; Issa Diarra; Marcelo A Fernández-Vina; Christopher V Plowe; Ogobara K Doumbo; Marcelo B Sztein
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

5.  Laser mimicking mosquito bites for skin delivery of malaria sporozoite vaccines.

Authors:  Chang Zhou; Xinyuan Chen; Qi Zhang; Ji Wang; Mei X Wu
Journal:  J Control Release       Date:  2015-02-25       Impact factor: 9.776

6.  Strain-specific immunity induced by immunization with pre-erythrocytic stages of Plasmodium chabaudi.

Authors:  R L Culleton; M Inoue; S E Reece; S Cheesman; R Carter
Journal:  Parasite Immunol       Date:  2011-01       Impact factor: 2.280

7.  CD8 T cell independent immunity after single dose infection-treatment-vaccination (ITV) against Plasmodium yoelii.

Authors:  Katherine L Doll; Noah S Butler; John T Harty
Journal:  Vaccine       Date:  2013-12-07       Impact factor: 3.641

8.  Development of an epitope panel for consistent identification of antigen-specific T-cells in humans.

Authors:  Andreas Fløe; Caroline Løppke; Ole Hilberg; Christian Wejse; Liselotte Brix; Kivin Jacobsen
Journal:  Immunology       Date:  2017-07-03       Impact factor: 7.397

9.  Advances and challenges in malaria vaccine development.

Authors:  Ruobing Wang; Joseph D Smith; Stefan H I Kappe
Journal:  Expert Rev Mol Med       Date:  2009-12-16       Impact factor: 5.600

10.  Meta-analysis of immune epitope data for all Plasmodia: overview and applications for malarial immunobiology and vaccine-related issues.

Authors:  K Vaughan; M Blythe; J Greenbaum; Q Zhang; B Peters; D L Doolan; A Sette
Journal:  Parasite Immunol       Date:  2009-02       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.